Wenyin Shi is serving as Professor of Radiation Oncology at Thomas Jefferson University, where GBM is the target of ongoing trials.
1 report, 1 independent
Updated Jun 18
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Wenyin Shi is serving as Professor of Radiation Oncology at Thomas Jefferson University, where GBM is the target of ongoing trials.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- A Phase III clinical trial overseen by the Jefferson Brain Tumor Center failed to show benefit for early initiation, leading to market consequences for the involved companies.Sub-event
Wenyin Shi appointed Professor of Radiation Oncology at Thomas Jefferson University for GBM trials.1 source
Keep exploring
The entities involved
-
Thomas Jefferson University
private university in Philadelphia, Pennsylvania
Nothing else this week.
-
Wenyin Shi
researcher
Nothing else this week.
-
GBM
South Korean esports player
Nothing else this week.